Female and male patients presented similar clinical and demographic features, amyloid, neurodegeneration (measured by MRI hippocampal volume, cortical thickness, and tau-PET early-phase hypoperfusion), and white matter changes (as measured by ARWMC and TLV). The gene discussed is MAPT; the disease is amyloidosis.